XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.750
-0.070 (-2.48%)
At close: Sep 12, 2025, 4:00 PM EDT
2.800
+0.050 (1.82%)
After-hours: Sep 12, 2025, 7:44 PM EDT
XBiotech Market Cap
XBiotech has a market cap or net worth of $83.84 million as of September 12, 2025. Its market cap has decreased by -57.66% in one year.
Market Cap
83.84M
Enterprise Value
-69.10M
1-Year Change
-57.66%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $83.84M, a decrease of -88.63%. That is a compound annual growth rate of -18.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 83.80M | -30.40% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |